Skip to main content

Table 3 Changes in selected parameters in Control and RESMENA groups after 8 weeks of nutritional intervention

From: Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial

Variable

Control group (n = 48)

Resmena group (n = 48)

 

Visit 1 (day 0)

Visit 2 (day 60)

p a

Visit 1 (day 0)

Visit 2 (day 60)

p b

p c

Weight (kg)

99.45 ± 19.21

92.72 ± 18.50

<0.001

100.00 ± 16.58

92.91 ± 15.76

<0.001

0.555

BMI (kg/m2)

36.15 ± 4.95

33.70 ± 4.80

<0.001

35.55 ± 4.40

33.03 ± 4.24

<0.001

0.732

Waist circumference (cm)

110.94 ± 13.41

104.18 ± 12.29

<0.001

111.25 ± 12.30

103.78 ± 11.66

<0.001

0.432

Waist/hip ratio

0.96 ± 0.10

0.94 ± 0.09

<0.001

0.96 ± 0.10

0.93 ± 0.10

<0.001

0.355

Bioimpedance Fat mass (kg)

38.97 ± 10.87

33.68 ± 10.22

<0.001

39.23 ± 9.50

33.84 ± 9.09

<0.001

0.886

DXA Fat mass (kg)

42.13 ± 10.18

37.50 ± 10.39

<0.001

42.56 ± 9.18

37.30 ± 8.95

<0.001

0.208

TC (mg/dl)

221 ± 39

204 ± 39

0.001

219 ± 48

203 ± 46

0.020

0.943

HDL-c (mg/dl)

46 ± 10

42 ± 9

0.001

43 ± 10

41 ± 10

0.050

0.158

LDL-c (mg/dl)

140 ± 36

133 ± 35

0.085

137 ± 41

131 ± 40

0.374

0.888

TC/HDL-c ratio

4.94 ± 1.02

4.96 ± 0.94

0.856

5.18 ± 1.24

5.04 ± 1.24

0.398

0.419

LDL-c/HDL-c ratio

3.09 ± 0.77

3.22 ± 0.78

0.178

3.20 ± 0.83

3.23 ± 0.92

0.803

0.623

TG (mg/dl)

176 ± 10

145 ± 70

0.005

194 ± 123

151 ± 99

<0.001

0.421

Glucose (mg/dl)

121.02 ± 33.87

107.98 ± 13.71

0.006

123.81 ± 37.82

110.22 ± 26.18

0.016

0.939

Insulin (IU/mg)

15.30 ± 11.46

9.32 ± 7.18

<0.001

14.36 ± 8.30

9.14 ± 6.13

<0.001

0.557

HOMA index

4.69 ± 3.77

2.61 ± 2.31

<0.001

4.48 ± 3.01

2.60 ± 2.00

<0.001

0.686

ALT (U/L)

37.60 ± 21.04

27.03 ± 10.70

<0.001

29.13 ± 11.59

29.28 ± 14.20

0.936

0.001

AST (U/L)

25.81 ± 10.84

20.68 ± 6.18

0.001

21.90 ± 6.01

22.20 ± 6.14

0.740

0.002

  1. BMI, Body Mass Index; DXA, Dual-energy X-ray Absorptiometry; HDL-c, High Density Lipoprotein-cholesterol; LDL-c, Low Density Lipoprotein-cholesterol; TG, Triglycerides; HOMA, Homeostasis Model Assessment; ALT, Alanine aminotransferase; AST, Aspartate aminotranferase. p < 0.05 was set-up as statistically significant.
  2. pa differences between baseline and final values in Control group. pb differences between baseline and final values in RESMENA group. pc differences between changes in Control group as compared with RESMENA group at the end of the intervention.
Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us